Clinical trial

A Study of LY3841136 in Healthy and Overweight Participants

NCT05295940

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-03-30

PhasePHASE1

Study timeline

Study start (actual)2022-03-30Date precision: day

Registry last updated2024-04-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Healthyunresolved

Interventions

LY3841136DRUG

PlaceboDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

DallasTexas, United States1 MadisonWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05295940 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.